Clinical best-practices when prescribing NVPs
Prescriber hub Clinical best-practices when prescribing NVPs First patient roadmap for prescribing...
Prescribers
Prescribing Nicovape® Q
Prescriber hub Prescribing Nicovape® Q Any Australian registered medical practitioner (including GPs)...
About Nicovape® Q
Prescriber hub About Nicovape® Q Liber launched its closed-system NVP, Nicovape® Q...
Clinical considerations
Prescriber hub Clinical considerations As with all smoking cessation therapies, using a...
Benefit/risk evaluation of NVPs
Prescriber hub Benefit/risk evaluation of NVPs Benefit/risk evaluation of NVPs The TGA...
The NVP-based approach to smoking cessation
Prescriber hub The NVP-based approach to smoking cessation The Unique Role of...
The role of NVPs in smoking cessation
Prescriber hub The role of NVPs in smoking cessation Smoking cessation: the...
The regulatory framework governing access to NVPs
Prescriber hub The regulatory framework governing access to NVPs Since 2021, accessing...
About Liber Pharmaceuticals
Prescriber hub About Liber Pharmaceuticals Smoking remains the primary cause of avoidable...
